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Eugene H. Blackstone, MDa,bFIGURE 1. T classification by size (greatest dimension). T1a, 2 cm;
T1b,>2 to 3 cm; T2a,>3 to 5 cm; T2b,>5 to 7 cm; T3, diam.>7 cm.The recently published 7th edition of the American Joint
Committee on Cancer (AJCC) Cancer Staging Manual in-
troduces a new, data-driven, and validated lung cancer stag-
ing system.1 It is based on 67,725 patients with non–small
cell lung cancer (NSCLC) assembled by the International
Association for the Study of Lung Cancer (IASLC) from
43 institutions.2 Cox regression analysis produced more
than 180 TNM subsets that were reduced to 8 stage group-
ings by recursive partitioning and amalgamation.
The new system addresses 3 problem areas: cancer size
(Figure 1), satellite nodules (Figure 2), and malignant effu-
sions (Figure 3). The resulting redefined T and M classifica-
tions require a few simple alterations of previous stage
grouping. Although derived from analysis of NSCLC data,
7th edition lung cancer staging is also recommended for
small cell lung cancer (SCLC) and carcinoid tumors.3,4
TNM CLASSIFICATIONS
Primary Tumor (T)
Primary tumor classification (T) is based on the greater of
either cancer size (greatest dimension) or local extent (extent
of local invasion). With respect to cancer size, T1 cancers are
dichotomized into T1a, which are2 cm and T1b, which are
>2 cm to 3 cm (Figure 1). T2 cancers are dichotomized into
T2a, which are>3 cm to 5 cm, and T2b, which are>5 cm to
7 cm (Figure 1). T3 cancers are>7 cm (Figure 1).
T is also based on local extent: (1) Invasion of visceral
pleura or the main airway 2 cm from the carina or atelec-
tasis or (2) obstructive pneumonitis extending to the hilum,
but not involving the entire lung (Figure 4), elevates cancers
otherwise classified as T1 to T2a. Cancers are T3 by local
extent (Figure 5) if there is (1) invasion of parietal pleura
or pericardium, chest wall, diaphragm, phrenic nerve, or me-
diastinal pleura, or main airway<2 cm from the carina but
without carinal involvement; (2) associated atelectasis or ob-
structive pneumonia of the entire lung; or (3) satellite nod-
ule(s) (separate tumor nodule[s]) in the same lobe (FiguresFIGURE 2. Classification of satellite nodules: T3, in same lobe; T4, in
a different ipsilateral lobe; and M1a, in contralateral lung.
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FIGURE 3. M1a cancer. Cancers associated with malignant pleural or
pericardial effusion, malignant pleural nodules, or those with satellite nod-
ules in contralateral lung (green).
FIGURE 4. T2a cancer by local invasion. Invasion of visceral pleura (pur-
ple) or main airway2 cm from the carina (red) or atelectasis or obstructive
pneumonia extending to the hilum, but not involving the entire lung (yel-
low), elevates cancers otherwise classified as T1 to T2a.
FIGURE 5. T3 cancer by local invasion: (1) invasion of parietal pleura or
pericardium, chest wall, diaphragm, phrenic nerve, or mediastinal pleura
(purple) or main airway<2 cm from the carina (red), without carinal in-
volvement; (2) associated atelectasis or obstructive pneumonia of the entire
lung (yellow); and (3) a satellite nodule in the same lobe (blue).
FIGURE 6. T4 cancer: Invasion of the mediastinum, heart, great vessels,
trachea, recurrent laryngeal nerve, esophagus, vertebral body, or carina
(red), or satellite nodules in a different ipsilateral lobe (orange).
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FIGURE 7. Lymph node map: Lymph node zones are supraclavicular (green), upper mediastinal (blue), aortopulmonary (gray), subcarinal (yellow), lower
mediastinal (orange), hilar/interlobar (pink), and peripheral (aqua).
TABLE 1. Lymph node zones
Supraclavicular zone
1 low cervical, supraclavicular and sternal notch nodes
Upper mediastinal zone
2R right upper paratracheal
2L left upper paratracheal
3a prevascular
3b retrotracheal
4R right lower paratracheal















14 subsegmental FIGURE 8. Stage groupings for M0 lung cancers.
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Rice et al Expert Commentaries2 and 5). T4 cancers are defined only by local extent and in-
clude cancers invading the mediastinum, heart, great vessels,
trachea, recurrent laryngeal nerve, esophagus, vertebral
body, or carina or those with satellite nodules in a different
ipsilateral lobe (Figures 2 and 6).
Regional Lymph Node (N)
Regional lymph node (N) classifications have not
changed. However, a unified lymph node map addresses dis-
crepancies among previous nodal mapping proposals and in-
troduces the concept of lymph node zones (Figure 7 and
Table 1).1,5 Anatomic boundaries of each of the lymph
node stations and 7 zones have been painstakingly defined.
Regional lymph node classifications are as follows: N0, no
regional lymph node metastases; N1, metastases involving
hilar/interlobar or peripheral regional lymph node zones;
N2, metastases involving ipsilateral upper mediastinal, sub-
carinal, lower mediastinal, or aortopulmonary regional
lymph node zones; and N3, metastases involving contralat-
eral upper mediastinal, lower mediastinal aortopulmonary,
hilar/interlobar or peripheral zones, or involving supracla-
vicular zone.
Distant Metastasis (M)
The subclassifications M1a (Figure 3) and M1b have been
added. M1a cancers are those with malignant pleural or peri-
cardial effusions, malignant pleural nodules, or satellite nod-
ules in the contralateral lung. All other sites of distant
metastases are classified as M1b. The classification Mx
has been eliminated.
Stage Groupings
Stage 0 is by definition TisN0M0. Stage groupings for M0
lung cancer are shown in Figure 8. The subclassification of
T1 does not alter stage group IA, which comprises
T1aN0M0 and T1bN0M0 cancers. Stage IB is only
T2aN0M0 cancers; this stage group continues to be clini-
cally problematic because it contains tumors both smaller
than 4 cm and 4 cm or larger, which a recent analysis sug-
gests is the cut point for patients with completely resected
cancers who may benefit from adjuvant chemotherapy.6The Journal of Thoracic and CaStage II groups smaller T cancers with N1 regional lymph
node metastases and larger T cancers free of regional lymph
node metastases. Stage IIA comprises T1aN1M0,
T1bN1M0, T2aN1M0, and T2bN0M0 cancers. Stage IIB
comprises T2bN1M0 and T3N0M0 cancers. Stage IIIA
comprises T3N1M0, T4N0M0, T4N1M0, and any N2M0
cancer except T4N2M0. Stage IIIB comprises T4N2M0
and any N3M0 cancer. Stage IV is by definition T any N
any M1 and is not altered by subclassification of M1.
CONCLUSIONS
The 7th edition of the AJCC Cancer Staging Manual pro-
vides refined lung cancer staging based on analysis of a large
international lung cancer database. Primary tumor classifica-
tion has been modified by addition of size (T1a, T1b, T2a,
T2b, and T3) and satellite nodules (T3 and T4). Subclassifi-
cation of M1a includes satellite nodules in the contralateral
lung, malignant pleural and pericardial effusions, and malig-
nant pleural nodules. Simple changes in stage groupings are
required by these TNM classification changes.References
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